Publication
Title
Radiotherapy for single station N2 NSCLC
Author
Abstract
Clinical single station N2 is a prognostic factor, which is only moderately identifiable preoperatively, even after adequate mediastinal staging. There is little evidence that single station N2 predicts for the outcome of any radical treatment strategy, or for a benefit of postoperative radiotherapy. In adequately staged patients with clinical single station N2 involvement, modern definitive chemoradiation therapy results in equivalent outcome as induction therapy followed by resection.
Language
English
Source (journal)
Translational lung cancer research. - -
Publication
2014
ISSN
2218-6751
Volume/pages
3:4(2014), p. 234-237
Full text (Publishers DOI)
Full text (publishers version - intranet only)
UAntwerpen
Faculty/Department
Research group
Publication type
Subject
Affiliation
Publications with a UAntwerp address
External links
Record
Identification
Creation 01.03.2016
Last edited 12.03.2017
To cite this reference